Viruses as therapeutic agents against malignant disease of the central nervous system

Journal of the National Cancer Institute

Volumn 93, Issue 12, 2001, Pages 889-890

  Gromeier, M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; ONCOLYTIC VIRUS; SIALOGLYCOPROTEIN; VIRUS ONCOLYSATE; VIRUS RECEPTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL JUNCTION; CELL KILLING; CELL SPECIFICITY; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; EDITORIAL; GENE THERAPY; GLIOBLASTOMA; GLIOMA; HERPES VIRUS; HOST CELL; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENICITY; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROGNOSIS; REOVIRUS; TISSUE GROWTH; TUMOR CELL; TUMOR XENOGRAFT; VESICULAR STOMATITIS VIRUS; VIRUS VIRULENCE;

EID: 0035918835     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.12.889     Document Type: Editorial

References (7)

1. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
2. Experimental therapy of human glioma by means of a genetically engineered virus mutant
3. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
4. Intergeneric poliovirus recombinants for the treatment of malignant glioma
5. Reovirus as an oncolytic agent against experimental human malignant gliomas
6. Reovirus therapy of tumors with activated Ras pathway
7. Junction adhesion molecule is a receptor for reovirus